HZN Earnings & Forecasts - Benzinga

SPY769.86+0.03%QQQ749.55−0.00%BTC/USD84,962.16+0.26%DIA511.70+0.12%GLD380.52+0.10%TLT77.53+0.06%

HZN

HZNNasdaq Private Market

Private market price is not available

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

HZN Earnings & Forecasts - Benzinga

HZN Earnings & Forecasts

HZN (HZN) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

HZN Guidance

Recent Earnings Results

Metric	Q3 '22	Q2 '22	Q1 '22	Q4 '21
Earnings Per Share (Non-GAAP)
Estimate	—	—	—	—
Actual	$-0.92	$-0.80	$-0.98	$-0.86
Surprise	—	—	—	—
Revenue
Estimate	$209.1M	$209.1M	$209.1M	$209.1M
Actual	$149.0M	$181.2M	$180.9M	$164.3M
Surprise	-28.7%	-13.3%	-13.5%	-21.4%

Earnings & Guidance News

PRO
Horizon Global Q3 EPS $(0.92) Down From $(0.09) YoY, Sales $148.97M Miss $209.05M Estimate

Horizon Global (NYSE:HZN) reported quarterly losses of $(0.92) per share. This is a 922.22 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of

Benzinga Newsdesk

Earnings Scheduled For November 9, 2022

Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million.

Benzinga Insights

PRO
Horizon Global Q2 EPS $(0.80) Down From $0.04 YoY, Sales $181.20M Miss $209.05M Estimate

Horizon Global (NYSE:HZN) reported quarterly losses of $(0.80) per share. This is a 2100 percent decrease over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $181.20

Benzinga Newsdesk

Earnings Scheduled For August 9, 2022

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.

Benzinga Insights

PRO
Horizon Global Q1 Sales $180.90M Miss $209.05M Estimate

Horizon Global (NYSE:HZN) reported quarterly sales of $180.90 million which missed the analyst consensus estimate of $209.05 million by 13.47 percent. This is a 9.18 percent decrease over sales of $199.19 million the

Benzinga Newsdesk

Earnings Scheduled For May 5, 2022

Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.

Benzinga Insights

Quarterly Revenue Surprise Amount

Fiscal Quarter	Date Reported	Actual Revenue	Estimated Revenue	Surprise %
Q3	Nov 9, 2022	$148.97M	$209.05M	-28.7 %
Q2	Aug 9, 2022	$181.22M	$209.05M	-13.3 %
Q1	May 5, 2022	$180.86M	$209.05M	-13.5 %
Q4	Mar 10, 2022	$164.27M	$209.05M	-21.4 %